ALB vs ASRT · rev $5.14B vs rev $125.0M
Albemarle Corp (ALB) versus Assertio Therapeutics Inc (ASRT) — a side-by-side from cached financials, not a winner call.
Albemarle Corp (ALB) is a specialty chemicals company listed on US.
Assertio Therapeutics Inc (ASRT) is a drug manufacturers - specialty & generic company listed on US.
Latest reported ALB revenue for 2025-12-31 was $5.14B. Net income was -$510.6M. Revenue was down 4.4% from 2024-12-31 to 2025-12-31. ALB currently screens at market cap $8.00B.
Latest reported ASRT revenue for 2024-12-31 was $125.0M. Net income was -$21.6M. Revenue was down 17.8% from 2023-12-31 to 2024-12-31. ASRT currently screens at market cap $151.5M.
ALB currently screens at market cap $8.00B. ASRT currently screens at market cap $151.5M.
Not investment advice. Open the ALB and ASRT stock pages for the full models.
Not investment advice.